“In some patients, combination therapy will have a greater effect than treatment with a single agent,” he said, noting that the study adds another option for care in those with severe postmenopausal osteoporosis.
He described the report as a well conducted randomized controlled trial that used state-of-the-art treatment and technology. “It marks an advance in our understanding of postmenopausal osteoporosis,” he said.